Identifying inflammatory phenotypes associated with lung involvement in systemic sclerosis: k-means clustering approach
Open Access
- 8 May 2025
- journal article
- immunology
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1568683
Abstract
Objective: to assess the prognostic impact of clusters of hematologic and biochemical indices on interstitial lung disease (ILD) and respiratory damage associated with systemic sclerosis (SSc)Methods: Design: We conducted a cross-sectional, uncontrolled study. Participants and Settings: a cohort of patients with SSc (2013 ACR/EULAR criteria) were enrolled in the rheumatology unit of a tertiary hospital in southern Spain. Primary and secondary outcome measures: The primary outcomes were the presence of SSc-ILD and respiratory damage, assessed via the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI). Inflammatory biomarkers, including both CRP and hematological indices, were obtained. Patients were grouped based on inflammatory phenotypes derived from longitudinal CRP averages and through principal component analysis (PCA) with K-means clustering of cross-sectional variables. Multivariate models were constructed to identify factors associated with SSc-ILD and respiratory damage.Results: Among 83 patients with SSc, 33.7% had ILD, 30.1% had respiratory damage, and 28.9% were receiving immunosuppressive therapy. A persistent inflammatory phenotype during follow-up was associated with non-Caucasian ethnicity (OR 14.0) and SSc-ILD (OR 17.9). Cross-sectional inflammatory clusters were linked to SSc-ILD (OR 12.8) and damage measured by SCTC-DI (OR 1.2). PC-2, derived from CRP-based variables, was a better predictor of SSc-ILD (OR 3.0) than PC-1, which was based on hematological indices (OR 0.5, non-significant), especially in the presence of anti-Scl70+ antibodies (OR 19.1) and immunosuppressants (OR 42.2). The only variables associated with respiratory damage were average CRP during follow-up (OR 1.2), anti-Scl70+ (OR 7.7), and glucocorticoids (OR 0.2).Conclusion: CRP-based variables seem to be better predictors of SSc-ILD and respiratory damage than hematological indices.Keywords
This publication has 41 references indexed in Scilit:
- Analysis of comorbidity in rheumatoid arthritis–associated interstitial lung disease: a nested case-cohort studyBiomedicine & Pharmacotherapy, 2022
- Blood Neutrophil Count and Neutrophil‐to‐Lymphocyte Ratio for Prediction of Disease Progression and Mortality in Two Independent Systemic Sclerosis CohortsArthritis Care & Research, 2022
- Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as potential makers for digital ulcers and interstitial lung disease in patients with systemic sclerosis: cross-sectional analysis of data from a prospective cohort studyRheumatology International, 2020
- Association of simple hematological parameters with disease manifestations, activity, and severity in patients with systemic sclerosisClinical Rheumatology, 2019
- Platelets in Systemic Sclerosis: the Missing Link Connecting Vasculopathy, Autoimmunity, and Fibrosis?Current Rheumatology Reports, 2019
- Does C‐Reactive Protein Predict the Long‐Term Progression of Interstitial Lung Disease and Survival in Patients With Early Systemic Sclerosis?Arthritis Care & Research, 2013
- Association of C‐reactive protein with high disease activity in systemic sclerosis: Results from the Canadian Scleroderma Research GroupArthritis Care & Research, 2012
- Valor de los índices de Charlson y la escala de riesgo quirúrgico en el análisis de la mortalidad operatoriaCirugía Española, 2010
- Acute-Phase Proteins in Patients with Systemic SclerosisClinical Rheumatology, 2000
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987